How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures

Diabetic Medicine

Volumn 20, Issue 5, 2003, Pages 368-374

  Rahman, M ^a   Griffin, S J ^a   Rathmann, W ^b   Wareham, N J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Monofilament; Neuropathy; Type 2 diabetes; Validity; Vibration threshold

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICHIGAN NEUROPATHY SCREENING INSTRUMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; ANTHROPOMETRY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK FACTORS; SENSORY THRESHOLDS; VIBRATION;

EID: 0037516757     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00931.x     Document Type: Article

References (24)

1. Ward JD. Improving prognosis in Type 2 diabetes. Diabetic neuropathy is in trouble. Diabetes Care 1999; 22: 84-88.
2. Boulton AJ. The diabetic foot: a global view. Diabetes/Metabolism Res Rev 2000; 16: S2-S5.
3. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331: 854-60.
4. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13: 513-521.
5. Boulton AJ. Clinical presentation and management of diabetic neuropathy and foot ulceration. Diabet Med 1991; 8 (Symposium): S52-S57.
6. Kamien M, Ward AM, Mansfield F, Fatovich B, Mather C, Anstey K. Management of type 2 diabetes in Western Australian metropolitan general practice. Diabetes Res Clin Pract 2001; 26: 197-208.
7. Khunti K, Baker R, Rumsey M, Lakhani M. Quality of care of patients with diabetes: collation of data from multi-practice audits of diabetes in primary care. Fam Pract 2001; 16: 54-59.
8. Valk GD, Nauta IJP, Stijers RJM, Bertelsmann FW. Clinical examination versus neurophysiological examination in the diagnosis of diabetic neuropathy. Diabet Med 1992; 9: 716-721.
9. Vinik A, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000; 43: 957-973.
10. Hughes RA. Peripheral neuropathy. BMJ 2002; 324: 466-469.
11. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 1998; 21: 72-80.
12. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998; 41: 1263-1269.
13. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20: 1162-1167.
14. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
15. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996; 19: 1243-1248.
16. Goldberg M, Lindblom U. Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry 1979; 42: 793-803.
17. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
18. Cuzick J. A Wilcoxon-type test for trend. Statistics Med 1985; 4: 87-90.
19. Gadia MT, Natori N, Ramos LB. Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care 1987; 10: 613-616.
20. Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JT. 'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients. Diabet Med 2000; 17: 105-110.
21. Davis EA, Walsh P, Jones TW, Byrne GC. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes Care 1997; 20: 1448-1453.
22. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994; 17: 557-560.
23. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991; 13: 63-67.
24. Olmos PR, Cataland S, O'Dorisio TM, Casey CA, Smead WL, Simon SR. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci 1995; 309: 76-82.